Dynavax Technologies
DVAX
#5491
Rank
A$1.94 B
Marketcap
A$16.53
Share price
-0.09%
Change (1 day)
-17.49%
Change (1 year)

Dynavax Technologies (DVAX) - P/B ratio

P/B ratio as of December 2025 : 2.41

According to Dynavax Technologies 's latest financial reports the company has a price-to-book ratio of 3.89387.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Dynavax Technologies - P/B ratio (from 2004 to 2025)

P/B ratio by year

Year P/B ratio Change
2025-12-31N/A-100%
2024-12-312.86-1.43%
2023-12-312.9024.33%
2022-12-312.34-69.22%
2021-12-317.59-9.15%
2020-12-318.35-85.56%
2019-12-3157.9534.5%
2018-12-319.1260.61%
2017-12-315.68232.84%
2016-12-311.71-65.64%
2015-12-314.9712.48%
2014-12-314.4159.65%
2013-12-312.76-39.06%
2012-12-314.547.63%
2011-12-314.22-40.63%
2010-12-317.10-41.27%
2009-12-3112.1483.38%
2008-12-312.07-60.1%
2007-12-315.1912.62%
2006-12-314.61244.02%
2005-12-311.34-57.63%
2004-12-313.16
2003-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Agenus
AGEN
-0.4916-120.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
1.47-39.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
4.85 101.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
7.09 194.31%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
6.07 152.02%๐Ÿ‡ฌ๐Ÿ‡ง UK
GlaxoSmithKline
GSK
4.63 92.15%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
1.57-34.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
4.49 86.49%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
19.0 690.33%๐Ÿ‡บ๐Ÿ‡ธ USA